Published in TB and Outbreaks Week, August 29th, 2006
"Nine months of isoniazid therapy is the recommended regimen for treatment of latent tuberculosis infection, but low completion rates are a serious problem. The search for shorter regimens, compared with the standard isoniazid regimen, is of vital importance.
"We describe our experience using short-course regimens for the treatment of latent tuberculosis infection. We conducted a nonrandomized, observational study of 459 patients in a county health department from June 2000 to January 2006," researchers in the United States report.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.